ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
122.12
-1.51 (-1.22%)
At close: Jan 23, 2026, 4:00 PM EST
122.99
+0.87 (0.71%)
After-hours: Jan 23, 2026, 7:56 PM EST
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $9.76 billion as of January 23, 2026. Its market cap has increased by 2,317.17% in one year.
Market Cap
9.76B
Enterprise Value
9.15B
1-Year Change
2,317.17%
Ranking
Category
Stock Price
$122.12
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $9.76B, an increase of 4,226.55%. That is a compound annual growth rate of 42.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 9.76B | -11.34% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avidity Biosciences | 10.94B |
| Madrigal Pharmaceuticals | 10.91B |
| BioMarin Pharmaceutical | 10.80B |
| Bio-Techne | 10.62B |
| Jazz Pharmaceuticals | 10.25B |
| Axsome Therapeutics | 9.37B |
| Arrowhead Pharmaceuticals | 9.21B |
| Praxis Precision Medicines | 8.65B |